Commentary: Do potential modifications in classificatory systems impact on child mental health in developing countries? Reflections on Rutter (2011)
Conflict of interest statement: Dr. Rohde takes part of the ADHD and Disruptive Behavior working group for the DSM-V and acted both as a co-chair of the Conference on Externalizing Disorders as part of the 13 international conferences on Research Possibilities for DSM-V co-sponsored by the APA and WHO and funded by NIMH and as member of the ICD-11 Global Scientific Partnership Coordination Group sponsored by WHO. However, the opinions expressed in this commentary do not reflect positions or views of any of these official institutions.
Dr. Rohde has been on the speakers’ bureau and/or acted as consultant for Eli-Lilly, Janssen-Cilag, Novartis and Shire in the past three years (less than U$10,000 per year and reflecting less than 5% of his gross income per year). He also received travel support (air tickets and hotel) from Novartis and Janssen-Cilag for attending two Child Psychiatric Meetings in 2010. The ADHD and Juvenile Bipolar Disorder Outpatient Programs chaired by him received unrestricted educational and research support from the following pharmaceutical companies in the past three years: Abbott, Bristol-Myers Squibb, Eli-Lilly, Janssen-Cilag, Novartis, and Shire. He also receives research support from Brazilian government institutions (CNPQ, FAPERGS, HCPA and CAPES).
No abstract is available for this article.